Stephane van Rooijen
Vorstandsvorsitzender bei Dynacure SA
Ursprung des Netzwerks ersten Grades von Stephane van Rooijen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.
14
| Subsidiary | Medical/Nursing Services | 14 |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Viropharma Ltd.
Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephane van Rooijen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
MDXHEALTH SA | Medical Specialties | Director/Board Member | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
POXEL | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
Sparflex SA
Sparflex SA Industrial MachineryProducer Manufacturing Sparflex SA provides packaging supplies. It offers wire hoods, capsules, and foils. The firm also offers consulting, branding, and design services. The company was founded by Jocelyne Soutiran and Michel Soutiran in 1984 and is headquartered in Epernay, France. | Industrial Machinery | Director/Board Member | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
VOYAGEURS DU MONDE | Other Consumer Services | Director/Board Member | |
Eurazeo Investment Manager - EIM SA
Eurazeo Investment Manager - EIM SA Investment ManagersFinance Eurazeo Investment Managr - EIM SA (Eurazeo IM) is a Venture Capital firm founded in 1997 by Christophe Bavière and part of the Eurazeo Group. Eurazeo Investment Manager - EIM SA is headquartered in Paris with additional offices in Frankfurt, Shanghai and Seoul. The firm is formerly known as Idinvest Partners SA, former AGF Private Equity SA. | Investment Managers | Private Equity Investor | |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member | |
THERADIAG | Medical Specialties | Director/Board Member | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Graduate Degree | |
IMPLANET SA | Medical Specialties | Director/Board Member | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chairman Director/Board Member | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Biospace Lab SA
Biospace Lab SA Electronic Equipment/InstrumentsElectronic Technology Biospace Lab SA develops and produces imaging tools. Its products include optical imaging systems and digital autoradiography solutions. The company was founded by Georges Charpak in 1989 and is headquartered in Nesles la Vallée, France. | Electronic Equipment/Instruments | Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
CDC Entreprises Innovation
CDC Entreprises Innovation Financial ConglomeratesFinance CDC Entreprises Innovation provides venture capital services. It invests in information technology, communication, life sciences and semi-conductor industries. The company is headquartered in France. | Financial Conglomerates | Corporate Officer/Principal | |
Key Neurosciences SAS
Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member Director of Finance/CFO | |
Axonics Europe SAS | Chief Executive Officer | ||
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Shire Biotech UK Holdings Ltd.
Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
DISC MEDICINE, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
CELLNOVO | Medical Specialties | Director/Board Member | |
Gamma Développement
Gamma Développement Miscellaneous Commercial ServicesCommercial Services Gamma Developpement engages in the financial industry providing business strategies and financial support solutions. The company was founded by Jean-Marc Duminil on May 3, 2010 and is headquartered in Combaillaux, France. | Miscellaneous Commercial Services | Director/Board Member | |
Winch Italy Holdings 1 SARL | Corporate Officer/Principal | ||
EPG Investment Partners SA | Chairman | ||
Winch Italy Holding 2 SARL | Director/Board Member |
Statistik
International
Frankreich | 24 |
Vereinigte Staaten | 13 |
Schweiz | 4 |
Niederlande | 4 |
Luxemburg | 4 |
Sektoral
Health Technology | 33 |
Finance | 7 |
Consumer Services | 4 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Operativ
Director/Board Member | 155 |
Corporate Officer/Principal | 49 |
Chairman | 32 |
Independent Dir/Board Member | 21 |
Chief Executive Officer | 15 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Raphaël Wisniewski | 45 |
Georges Gemayel | 33 |
Chris Mirabelli | 29 |
Henry Skinner | 29 |
Rémi Droller | 29 |
Jan Steyaert | 18 |
Frédéric Chéreau | 17 |
Jean Franchi | 17 |
Brett Monia | 13 |
David Garrett | 9 |
Frédéric Legros | 7 |
Kentaro Shirahata | 7 |
Helen Lillistone | 6 |
Benoit Barteau | 6 |
Chris Freitag | 5 |
- Börse
- Insiders
- Stephane van Rooijen
- Unternehmensverbindungen